Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
The Journal of Endocrinology|August 9, 2003
The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancerC S Mitsiades, V Poulaki, N MitsiadesDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 7, 2002
The role of Fas and FasL as mediators of anticancer chemotherapyV Poulaki, C S Mitsiades, N MitsiadesJournal of the National Cancer Institute|October 8, 1999
Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitorsN Mitsiades, V Poulaki, A Leone, et al.Cancer Research|April 6, 2001
Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5N Mitsiades, V Poulaki, C Mitsiades, et al.Cancer Research|June 19, 2001
Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2V Poulaki, N Mitsiades, M E Romero, et al.The American Journal of Pathology|December 10, 1998
Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinaseN Mitsiades, V Poulaki, V Kotoula, et al.Journal of Neuroscience Research|May 26, 1999
p53 expression and regulation by NMDA receptors in the developing rat brainV Poulaki, A Benekou, E Bozas, et al.Expert Opinion on Investigational Drugs|January 5, 2002
Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drugN Mitsiades, V Poulaki, C S Mitsiades, et al.Cancer Research|February 24, 2001
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicityN Mitsiades, W H Yu, V Poulaki, et al.Pageof 3